A 51-Year-Old Woman with Drug-Induced Hypersensitivity Syndrome Associated with Carbamazepine, Reactivation of Human Herpesvirus 6, and Acute Liver Failure: A Case Report

28 January 2021 : Case report Japan

Mistake in diagnosis, Unusual or unexpected effect of treatment, Diagnostic / therapeutic accidents, Rare disease, Adverse events of drug therapy

Akio Miyasaka^1ABCDE*, Ichiro Kumagai^2BD, Tomoyuki Masuda^3CD, Yasuhiro Takikawa^1A

DOI: 10.12659/AJCR.928587

Am J Case Rep 2021; 22:e928587

Background Case Report Discussion Conclusions References:

Related articles Order reprints Share article Share by email

View HTML version

Table 3. Infectious disease markers on day 13 after admission.

Infection marker
HBs Ag	0.1	IU/mL
HCV Ab	0.1	S/CO
HEV IgM	<5
HEV IgG	<5
CMV IgM	<×10
CMV IgG	×160
CMV antigen	Negative
EBV-VCA-IgM	<×10
EBV-VCA-IgG	×10
EBV-EBNA	<×10
HPV B19 IgM	0.45
HPV B19 IgG	1.13
HSV IgM	<×10
HSV IgG	×40
HHV-6 IgM	×10
HHV-6 IgG	×640
IgM	<×10
IgG	<×10
Endotoxin	<1.0	pg/mL
β-D-glucan	<6.0	pg/mL
HBs Ag – anti-hepatitis B surface antibody; HCV Ab – anti-hepatitis C antibody; CMV – Cytomegalovirus; EBV – Epstein-Barr virus; HPV B19 – human parvovirus B19; HSV – herpes simplex virus; HHV-6 – human herpesvirus 6.

Back to the Article